Asteria C, Oliveira J H, Abucham J, Beck-Peccoz P
Institute of Endocrine Sciences, University of Milan, Ospedale Maggiore IRCCS, Milan, Italy.
Eur J Endocrinol. 2000 Sep;143(3):347-52. doi: 10.1530/eje.0.1430347.
One of the causes of combined pituitary hormone deficiency (CPHD) is represented by Prophet of Pit-1 (PROP-1) gene inactivating mutations. This disorder is generally characterized by GH, TSH, prolactin (PRL), and gonadotropin deficiency, but recent papers have described a concomitant alteration of the corticotrope function.
To make a detailed investigation of the hypothalamic-pituitary-adrenal axis in two sisters with PROP-1 gene mutations.
Two female siblings (17 and 16 years old) with CPHD, belonging to a Brazilian family of consanguineous parents, presented with growth retardation and central hypothyroidism during childhood, and showed central hypogonadism at the age of puberty. No clear clinical symptoms and signs of hypocortisolism were present.
GH, TSH, free thyroxine, total tri-iodothyronine, PRL, LH, FSH, ACTH and cortisol were measured in basal condition and after appropriate testing. The molecular study was performed by PCR amplification and sequencing analysis of PROP-1 gene.
Both patients showed GH, PRL, LH and FSH deficiencies, associated with absent responses to an insulin tolerance test (ITT), TRH and GnRH injection. Circulating concentrations of TSH were normal in basal conditions, but failed to respond to a TRH test. Plasma ACTH concentrations were normal, but serum cortisol concentrations were below the lower limit of the normal range, showing a trend to decrease during 6 years of follow-up. The serum ACTH response to ITT was impaired, whereas its response to CRH was normal and prolonged. The cortisol response to both tests, and to the ACTH test, was clearly impaired. In both sisters, the genetic analysis showed the presence of a homozygous 2-bp deletion (296delGA) of PROP-1 gene, which results in the synthesis of a protein with no residual functional activity.
In addition to GH, TSH, PRL and gonadotropin deficiency, patients with PROP-1 gene mutations can present with late-onset central hypocortisolism, possibly beause of the lack of important paracrine factors normally produced by the cells surrounding the corticotropes and absent in the pituitary of these patients, or because of progressive corticotrope apoptosis. This finding indicates the need for life-long endocrine monitoring of PROP-1-deficient patients.
垂体特异性转录因子(PROP-1)基因失活突变是导致联合垂体激素缺乏症(CPHD)的原因之一。这种疾病通常表现为生长激素(GH)、促甲状腺激素(TSH)、催乳素(PRL)和促性腺激素缺乏,但最近的文献报道了促肾上腺皮质激素细胞功能的伴随改变。
详细研究两名携带PROP-1基因突变的姐妹的下丘脑-垂体-肾上腺轴。
两名患有CPHD的女性同胞(分别为17岁和16岁),来自巴西一个近亲结婚的家庭,童年期出现生长发育迟缓及中枢性甲状腺功能减退,青春期出现中枢性性腺功能减退。无明显的皮质醇增多症临床症状和体征。
在基础状态及适当检测后测定GH、TSH、游离甲状腺素、总三碘甲状腺原氨酸、PRL、促黄体生成素(LH)、促卵泡生成素(FSH)、促肾上腺皮质激素(ACTH)和皮质醇。通过PROP-1基因的聚合酶链反应(PCR)扩增和测序分析进行分子研究。
两名患者均表现出GH、PRL、LH和FSH缺乏,对胰岛素耐量试验(ITT)、促甲状腺激素释放激素(TRH)和促性腺激素释放激素(GnRH)注射无反应。基础状态下TSH的循环浓度正常,但对TRH试验无反应。血浆ACTH浓度正常,但血清皮质醇浓度低于正常范围下限,在6年随访期间呈下降趋势。血清ACTH对ITT的反应受损,而对促肾上腺皮质激素释放激素(CRH)的反应正常且延长。皮质醇对两种试验及ACTH试验的反应均明显受损。在两姐妹中,基因分析均显示存在PROP-1基因纯合2碱基缺失(296delGA),导致合成的蛋白质无残余功能活性。
除了GH、TSH、PRL和促性腺激素缺乏外,携带PROP-1基因突变的患者可能会出现迟发性中枢性皮质醇增多症,这可能是由于缺乏促肾上腺皮质激素细胞周围正常产生的重要旁分泌因子,而这些患者的垂体中不存在这些因子,或者是由于促肾上腺皮质激素细胞的进行性凋亡。这一发现表明对PROP-1缺乏症患者需要进行终身内分泌监测。